Arthritis psoriatica: vizsgálatok itt: Olaszország
16 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 10.. Ask the study team whether a trial fits you.
- 4. fázisTaking peopleAn open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the investigator to benefit from continued Secukinumab treatment
- Where
- Florence, Reggio Emilia
- People
- 339 worldwide
- Run by
- Novartis Pharma AG
See details and how to joinNCT04638647 · EU 2023-504417-67-00 - 3. fázisTaking peopleA Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
- Where
- Brescia, Chieti, Genova, Milan, Naples, Palermo, Trieste
- Életkor
- 1 év to 18 év
- People
- 190 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT03773965 - 3. fázisTaking peopleA Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Where
- Bergamo, Bologna, Rome, San Giovanni Rotondo, Trieste
- Életkor
- 3 év to 64 év
- People
- 196 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00 - No phaseTaking peopleA Study of Guselkumab in Participants With Psoriatic Arthritis (PsA) in a Real-World Setting
- Where
- Bari, Brescia, Iesi, Milan, Naples, Palermo, Pavia, Perugia, Pisa, Potenza, Reggio Emilia, Roma, Siena, Torino, Varese, Verona
- Életkor
- 18 év and over
- People
- 200
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07220824 - No phaseTaking peopleObservational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- Where
- Rome
- Életkor
- Up to 21 év
- People
- 20 000 worldwide
- Run by
- Duke University
See details and how to joinNCT02418442 - 3. fázisTaking peopleApremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis
- Where
- Chieti, Genoa, Milan, Rome
- Életkor
- 5 év to 17 év
- People
- 60 worldwide
- Run by
- Amgen
See details and how to joinNCT04804553 · EU 2023-503435-17-00 - 3. fázisTaking peopleA Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
- Where
- Ancona, Florence, Milan, Padova, Pisa, Rome, Rozzano
- Életkor
- 18 év and over
- People
- 1088 worldwide
- Run by
- Takeda
See details and how to joinNCT06671483 · EU 2024-513111-27-00 - 2. fázisNot yet taking people in OlaszországAn Exploratory Phase II, Randomized, Open-Label, Proof-of-Concept Trial Evaluating Add-on Polyunsaturated Fatty Acid Ethyl Esters on Pain and Minimal Disease Activity in Psoriatic Arthritis Patients Starting TNF-alpha Inhibitors
- Where
- Rome, Udine
- Életkor
- 18 év and over
- People
- 50
- Run by
- Fondazione Policlinico Universitario Campus Bio-medico In Forma A Bbreviata Fon
See details and how to join2026-526768-20-00 · EU 2026-526768-20-00 - 3. fázisTaking peopleA Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis
- Where
- Florence, Naples
- Életkor
- 5 év to 17 év
- People
- 60 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06869551 · EU 2024-517262-41-00 - 3. fázisTaking peopleAn unblinded clinical Trial with random assignment to Treatment Groups in adult patients with psoriatic arthrits to evaluate how far immunosuppressive medication can be tapered without recurrence of symptoms
- Where
- Rome
- Életkor
- 18 év and over
- People
- 370 worldwide
- Run by
- Universitaetsklinikum Erlangen AöR
See details and how to join2023-508251-39-00 · EU 2023-508251-39-00 - 4. fázisTaking peopleIDENTIFICATION OF SYNOVIAL BIOMARKERS OF RESPONSE TO IXEKIZUMAB IN REFRACTORY PSORIATIC ARTHRITIS: THE PRECISE STUDY.
- Where
- Ferrara, Monza, Udine
- Életkor
- 18 év and over
- People
- 30
- Run by
- University Hospital Of Ferrara
See details and how to join2025-521259-21-00 · EU 2025-521259-21-00 - 3. fázisTaking peopleContinuation Study of Zasocitinib in Adults With Psoriatic Arthritis
- Where
- Ancona, Florence, Milan, Padova, Pisa, Rome, Rozzano
- Életkor
- 18 év and over
- People
- 1182 worldwide
- Run by
- Takeda
See details and how to joinNCT07286058 · EU 2025-522586-30-00 - 3. fázisTaking peopleA Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- Where
- Florence, Milan, Rome
- Életkor
- 5 év to 17 év
- People
- 40 worldwide
- Run by
- AbbVie
See details and how to joinNCT06100744 · EU 2023-506026-36-00 - No phaseTaking peopleAn Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis
- Where
- Ancona, Brescia, Campobasso, Catania, Chieti, Milan, Naples, Pisa, Rome, Rozzano, Siena, Udine
- Életkor
- 18 év to 75 év
- People
- 1200 worldwide
- Run by
- AbbVie
See details and how to joinNCT06764693 - 4. fázisNot yet taking people in OlaszországArthritis interception with Guselkumab in subclinical psoriatic arthritis patients in clinical transition from skin to joint disease: a randomized clinical trial.
- Where
- Ancona, Brunico, Ferrara, Udine
- Életkor
- 18 év and over
- People
- 90
- Run by
- Azienda Sanitaria Universitaria Friuli Centrale
See details and how to join2025-523551-54-00 · EU 2025-523551-54-00 - 3. fázisNot yet taking people in OlaszországClinical and ultrasound assessment of the therapeutic response to ixekizumab in psoriatic arthritis dactlylitis; a multicentre, parallel-groups, randomised controlled trial
- Where
- Ancona, Milan, Padova, Palermo, Pavia, Perugia, Roma, Rome, Turin
- Életkor
- 18 év and over
- People
- 60
- Run by
- Azienda Ospedaliera Ordine Mauriziano Di Torino
See details and how to join2022-503119-40-00 · EU 2022-503119-40-00